We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

225 hedge funds and large institutions have $609M invested in Editas Medicine in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 74 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $9.68M

27% more capital invested

Capital invested by funds: $481M → $609M (+$128M)

15% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 34

2% more funds holding

Funds holding: 220 → 225 (+5)

1.21% less ownership

Funds ownership: 74.77% → 73.56% (-1.2%)

28% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 74

Holders
225
Holders Change
+5
Holders Change %
+2.27%
% of All Funds
3.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
53
Reduced
74
Closed
34
Calls
$13.5M
Puts
$9.68M
Net Calls
+$3.87M
Net Calls Change
+$1.26M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$10.5M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$6.06M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.07M
4
Voloridge Investment Management
Voloridge Investment Management
Florida
+$4.88M
5
Citadel Advisors
Citadel Advisors
Florida
+$4.7M

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$20.8M
2
DTC
Deep Track Capital
Connecticut
-$14.3M
3
Marshall Wace
Marshall Wace
United Kingdom
-$9.51M
4
State Street
State Street
Massachusetts
-$6.16M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$2.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
Axa
226
Axa
France
– -$741K -95,000 Closed
JWCA
227
J.W. Cole Advisors
Florida
– -$660K -84,661 Closed
PHS
228
PFM Health Sciences
California
– -$642K -82,281 Closed
QCM
229
QRG Capital Management
Illinois
– -$635K -81,442 Closed
DTL
230
Dynamic Technology Lab
Singapore
– -$348K -44,675 Closed
AQR Capital Management
231
AQR Capital Management
Connecticut
– -$288K -36,933 Closed
DFCM
232
Dark Forest Capital Management
Puerto Rico
– -$272K -34,920 Closed
BCM
233
Bayesian Capital Management
New York
– -$243K -31,200 Closed
Simplex Trading
234
Simplex Trading
Illinois
– -$224K -25,507 Closed
Mercer Global Advisors
235
Mercer Global Advisors
Colorado
– -$184K -23,576 Closed
GCP
236
GSA Capital Partners
United Kingdom
– -$157K -20,141 Closed
TLP
237
Tri Locum Partners
New York
– -$151K -19,295 Closed
SPC
238
Sigma Planning Corp
Michigan
– -$114K -14,558 Closed
OQS
239
Occudo Quantitative Strategies
Florida
– -$113K -14,500 Closed
CA
240
Calton & Associates
Florida
– -$105K -13,420 Closed
PCM
241
Penserra Capital Management
California
– -$96K -12,348 Closed
PFGIA
242
Patriot Financial Group Insurance Agency
Massachusetts
– -$86.6K -11,106 Closed
IAA
243
Independent Advisor Alliance
North Carolina
– -$80.7K -10,348 Closed
SSG
244
Summit Securities Group
New York
– -$44K -5,679 Closed
MCM
245
Manchester Capital Management
Vermont
– -$31.2K -4,000 Closed
WWP
246
WR Wealth Planners
Missouri
– -$18.5K -2,375 Closed
Federated Hermes
247
Federated Hermes
Pennsylvania
– -$15.1K -1,941 Closed
Parallax Volatility Advisers
248
Parallax Volatility Advisers
California
– -$14.4K -1,845 Closed
TIM
249
Tortoise Investment Management
New York
– -$5.34K -685 Closed
TPCW
250
TD Private Client Wealth
New York
– -$4.06K -520 Closed
7 8 9
10
11

EDIT Hedge Fund Activity: Q4 2023 in Review

225 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2023, worth a combined $609M — up 27% from $481M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new EDIT positions and 34 closed out — a net gain of 5 holders — while 53 added to existing stakes and 74 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $10.5M. The largest seller was Woodline Partners, cutting an estimated $20.8M.

  • 225 institutional investors held Editas Medicine (EDIT) as of Q4 2023, up from 220 in Q3 2023.
  • Funds reported $609M of Editas Medicine stock for Q4 2023, up 27% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q4 2023 and 34 closed out, a net change of +5 holders.
  • The largest Editas Medicine buyer in Q4 2023 was Morgan Stanley, an estimated $10.5M added.
  • The largest Editas Medicine seller in Q4 2023 was Woodline Partners, an estimated $20.8M sold.

Based on aggregated 13F filings for Q4 2023.